AGF Investments Inc’s BioNTech BNTX Stock Holding History

AGF Investments Inc’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15	Closed	-$1K	–	816
2020 Q1	$1K	Buy	+15	New	+$584	﹤0.01%	782

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

AGF Investments Inc's BNTX Position: Q2 2020 in Review

AGF Investments Inc sold out of BioNTech (BNTX) in Q2 2020, closing a stake of 15 shares — an estimated $1K sold.

AGF Investments Inc first reported a position in BNTX in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 109 funds tracked by Wall St. Rank hold BNTX as of Q2 2020.

AGF Investments Inc reported no remaining BioNTech position as of Q2 2020 after selling out during the quarter.
AGF Investments Inc sold 15 BioNTech shares in Q2 2020, an estimated $1K.
AGF Investments Inc first reported a position in BioNTech in Q1 2020 and held it in 1 quarter.
AGF Investments Inc's BioNTech position peaked at $1K in Q1 2020.
109 funds tracked by Wall St. Rank held BioNTech as of Q2 2020.

Based on AGF Investments Inc's 13F filing for Q2 2020, filed 11 Aug 2020.